Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 347

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

NFKB1: a suppressor of inflammation, ageing and cancer

Open access
Cartwright, Tyrell, Perkins, Neil D., L. Wilson, Caroline · 2016 · The FEBS Journal

Abstract

The pleiotropic consequences of nuclear factor of kappa light polypeptide gene enhancer in B‐cells (NF‐κB) pathway activation result from the combinatorial effects of the five subunits that form the homo‐ and heterodimeric NF‐κB complexes. Although biochemical and gene knockout studies have demonstrated overlapping and distinct functions for these proteins, much is still not known about the mechanisms determining context‐dependent functions, the formation of different dimer complexes and transcriptional control in response to diverse stimuli. Here we discuss recent results that reveal that the nuclear factor of kappa light polypeptide gene enhancer in B‐cells 1 (NFKB 1) (p105/p50) subunit is an important regulator of NF‐κB activity in vivo. These effects are not restricted to being a dimer partner for other NF‐κB subunits. Rather p50 homodimers have a critical role as suppressors of the NF‐κB response, while the p105 precursor has a variety of NF‐κB‐independent functions. The importance of Nfkb1 function can be seen in mouse models, where Nfkb1−/− mice display increased inflammation and susceptibility to certain forms of DNA damage, leading to cancer, and a rapid ageing phenotype. In humans, low expression of Kip1 ubiquitination‐promoting complex 1 (KPC 1), a ubiquitin ligase required for p105 to p50 processing, was shown to correlate with a reduction in p50 and glioblastoma incidence. Therefore, while the majority of research in this field has focused on the upstream signalling pathways leading to NF‐κB activation or the function of other NF‐κB subunits, such as RelA (p65), these data demonstrate a critical role for NFKB 1, potentially revealing new strategies for targeting this pathway in inflammatory diseases and cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/febs.13627

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 347

Metadata

Authors
Cartwright, T., Perkins, N. D., & L. Wilson, C.
Venue
The FEBS Journal
Publisher
Wiley
Published
2016-01-13
Volume
283
Issue
10
Pages
1812-1822
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W2284475971
Cited by
347
References
70
FWCI
2.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NFKB1: a suppressor of inflammation, ageing and cancer. https://app.cochat.ai/papers/10.1111/febs.13627
The paper
Cartwright, T., Perkins, N. D., & L. Wilson, C. (2016). NFKB1: a suppressor of inflammation, ageing and cancer. The FEBS Journal. https://doi.org/10.1111/febs.13627

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.